Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP913972.RAN-4mFbq7TeV_KFk8eTo8eGineEmCUlwDsFS2nyjRc1I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP913972.RAN-4mFbq7TeV_KFk8eTo8eGineEmCUlwDsFS2nyjRc1I130_assertion type Assertion NP913972.RAN-4mFbq7TeV_KFk8eTo8eGineEmCUlwDsFS2nyjRc1I130_head.
- NP913972.RAN-4mFbq7TeV_KFk8eTo8eGineEmCUlwDsFS2nyjRc1I130_assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913972.RAN-4mFbq7TeV_KFk8eTo8eGineEmCUlwDsFS2nyjRc1I130_provenance.
- NP913972.RAN-4mFbq7TeV_KFk8eTo8eGineEmCUlwDsFS2nyjRc1I130_assertion evidence source_evidence_literature NP913972.RAN-4mFbq7TeV_KFk8eTo8eGineEmCUlwDsFS2nyjRc1I130_provenance.
- NP913972.RAN-4mFbq7TeV_KFk8eTo8eGineEmCUlwDsFS2nyjRc1I130_assertion SIO_000772 12623843 NP913972.RAN-4mFbq7TeV_KFk8eTo8eGineEmCUlwDsFS2nyjRc1I130_provenance.
- NP913972.RAN-4mFbq7TeV_KFk8eTo8eGineEmCUlwDsFS2nyjRc1I130_assertion wasDerivedFrom befree-20150227 NP913972.RAN-4mFbq7TeV_KFk8eTo8eGineEmCUlwDsFS2nyjRc1I130_provenance.
- NP913972.RAN-4mFbq7TeV_KFk8eTo8eGineEmCUlwDsFS2nyjRc1I130_assertion wasGeneratedBy ECO_0000203 NP913972.RAN-4mFbq7TeV_KFk8eTo8eGineEmCUlwDsFS2nyjRc1I130_provenance.